Europe

NIHR Clinical Research Network studies hit record high

Tuesday, May 31, 2011 03:32 PM

The number of commercial studies adopted into the National Institute for Health Research’s Clinical Research Network (NIHR CRN) Portfolio in England during the third quarter of 2010-2011 reached 115, the highest level since the network started compiling quarterly reports in 2008, according to PharmaTimes.

More... »

German CRO opens U.K. subsidiary

Thursday, May 26, 2011 02:37 PM

Accovion, a European CRO based in Eschborn, Germany, has extended its reach into what it terms a “key strategic territory” with a new subsidiary, Accovion Ltd., in Windsor, U.K., according to PharmaTimes.

More... »

Leeds Cancer Research sees 2,000 trial participants

Wednesday, May 25, 2011 11:57 AM

More than 2,000 cancer patients have signed up for clinical trials at the Leeds Cancer Research U.K. Center since its official opening last year, according to a report on BioscienceTechnology.com.

More... »

Amsterdam Molecular Therapeutics shows data supporting role of chylomicron clearance as marker for Glybera efficacy

Friday, May 20, 2011 11:10 AM

Amsterdam Molecular Therapeutics, a company involved in the field of human gene therapy, has results from a long-term efficacy study of Glybera (alipogene tiparvovec) that showed improved chylomicron metabolism could be used as a biomarker for increased lipoprotein lipase (LPL) activity in those patients missing the gene that produces this protein. Glybera is a gene therapy product under development for the treatment of lipoprotein lipase deficiency (LPLD) that is currently under review for marketing approval with the EMA.

More... »

Leukemia charity invests $3.7 million for trial network

Thursday, May 19, 2011 10:42 AM

Leukemia & Lymphoma Research, a U.K. charity, is investing $3.7 million in a national network of clinical trial centers to improve chances of survival for people suffering from leukaemia, lymphoma and myeloma.

More... »

Harmac to create 100 jobs in Ireland

Monday, May 16, 2011 12:42 PM

U.S. medical device maker Harmac will create 100 new jobs as part of an expansion in Roscommon, Ireland, says Fierce Medical Devices.

More... »

CMR analysis finds low phase II success rates

Friday, May 13, 2011 11:30 AM

Within the clinical trial industry, phase II success rates are lower than other stages of drug development and are getting worse, reports an analysis by the U.K.’s Center for Medicines Research (CMR), according to Pharma Times.

More... »

Quotient, KWS partner in antimicrobial drug discovery

Tuesday, May 10, 2011 12:25 PM

Two U.K.-based providers of early-stage and other drug development services, Quotient Bioresearch and KWS BioTest, have partnered to offer coordinated “plate to patient” support for clients engaged in the discovery and development of new antimicrobial agents, according to Pharma Times.

More... »

Cimzia shows positive results in RA patients

Tuesday, May 10, 2011 12:02 PM

UCB published results from a post hoc analysis of the RAPID 2 study in the Annals of Rheumatic Diseases, which showed Cimzia, the only approved PEGylated anti-TNF, plus methotrexate (MTX) provided rapid relief from a broad range of symptoms associated with the burden of moderate to severe active rheumatoid arthritis (RA). Adult patients treated with Cimzia that achieved early responses were found to have an increased chance of achieving longer-term outcomes.

More... »

Nycomed and Almirall partner to market COPD drug

Thursday, May 5, 2011 11:54 AM

Nycomed and Almirall will become marketing partners for the chronic obstructive pulmonary disease (COPD) treatment Daxas. The two firms have entered into a co-branding agreement covering Spain for Daxas (roflumilast), Nycomed's once-daily COPD tablet, according to Pharma Times.

More... »